Diagnos Laboratorium Utama PT Tbk (DGNS)

Currency in IDR
153
+1(+0.66%)
Delayed Data·
DGNS Scorecard
Full Analysis
Trading at a low Price / Book multiple
DGNS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
152154
52 wk Range
121380
Key Statistics
Bid/Ask
153.00 / 154.00
Prev. Close
152
Open
154
Day's Range
152-154
52 wk Range
121-380
Volume
39.5K
Average Volume (3m)
7.04M
1-Year Change
-24%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DGNS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Providers & Services industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Diagnos Laboratorium Utama PT Tbk Company Profile

PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want to have a child, oncology tests, drug sensitivity, DNAandMe, and others. It also offers homecare health services for hemoglobin, ferritin, retilulosit, hematologi rutin, SARS-COV-2 omicron screening molecular test, and PCR SARS-COV-2 H+1 B2C; and SARS-CoV-2 screening services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.

Compare DGNS to Peers and Sector

Metrics to compare
DGNS
Peers
Sector
Relationship
P/E Ratio
−74.8x9.5x−0.5x
PEG Ratio
−1.610.000.00
Price/Book
1.0x1.3x2.6x
Price / LTM Sales
1.2x2.2x3.3x
Upside (Analyst Target)
-20.3%45.1%
Fair Value Upside
Unlock8.0%7.4%Unlock

Earnings

Latest Release
Jul 30, 2025
EPS / Forecast
-0.32 / --
Revenue / Forecast
39.69B / --
EPS Revisions
Last 90 days

DGNS Income Statement

People Also Watch

52
CPRO
+1.96%
1,365
DSNG
-1.44%
1,125
IPCC
0.00%
356
FAST
+3.49%
332
SMDR
+0.61%

FAQ

What Stock Exchange Does Diagnos Laboratorium Utama PT Tbk Trade On?

Diagnos Laboratorium Utama PT Tbk is listed and trades on the Jakarta Stock Exchange stock exchange.

What Is the Stock Symbol for Diagnos Laboratorium Utama PT Tbk?

The stock symbol for Diagnos Laboratorium Utama PT Tbk is "DGNS."

What Is the Diagnos Laboratorium Utama PT Tbk Market Cap?

As of today, Diagnos Laboratorium Utama PT Tbk market cap is 190.00B.

What Is Diagnos Laboratorium Utama PT Tbk's Earnings Per Share (TTM)?

The Diagnos Laboratorium Utama PT Tbk EPS (TTM) is -2.03.

From a Technical Analysis Perspective, Is DGNS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Diagnos Laboratorium Utama PT Tbk Stock Split?

Diagnos Laboratorium Utama PT Tbk has split 0 times.

How Many Employees Does Diagnos Laboratorium Utama PT Tbk Have?

Diagnos Laboratorium Utama PT Tbk has 88 employees.

What is the current trading status of Diagnos Laboratorium Utama PT Tbk (DGNS)?

As of 04 Aug 2025, Diagnos Laboratorium Utama PT Tbk (DGNS) is trading at a price of 153.00, with a previous close of 152.00. The stock has fluctuated within a day range of 152.00 to 154.00, while its 52-week range spans from 121.00 to 380.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.